Innovators are increasingly focused on whether outsourced partners can help them make better decisions earlier, before uncertainty becomes late-stage risk.
Katie Edgar
Advertisement
Katie Edgar is chief business officer at KBI Biopharma.
Articles by Katie Edgar
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
4
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
5